je.st
news
UPDATE 1-U.S. health insurers say Gilead hepatitis C drug too costly
2014-05-21 03:50:55| Biotech - Topix.net
The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels.
Tags: health
too
update
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||